Rite Aid Corporation (NYSE: RAD) today announced sales results for May. Monthly SalesFor the five weeks ended May 28, 2011, same store sales increased 1.3 percent over the prior-year period. May front-end same store sales increased 1.8 percent while pharmacy same store sales, which included an approximate 129 basis points negative impact from new generic introductions, increased 1.0 percent. Prescription count at comparable stores increased 0.1 percent over the prior-year period. Total drugstore sales for the five-week period increased 1.0 percent to $2.463 billion compared to $2.439 billion for the same period last year. Prescription revenue accounted for 68.6 percent of drugstore sales, and third party prescription revenue represented 96.4 percent of pharmacy sales. Quarterly SalesSame store sales for the 13-week quarter ended May 28, 2011 increased 0.8 percent over the prior-year period. Front-end same store sales were flat compared to the prior-year period while pharmacy same store sales increased 1.1 percent. Prescription count at comparable stores increased 0.4 percent over the prior-year period. Total drugstore sales for the 13-week first quarter were flat with sales of $6.366 billion compared to $6.368 billion for the same period last year. Prescription revenue represented 68.7 percent of total drugstore sales, and third party prescription revenue was 96.5 percent of pharmacy sales. Rite Aid is one of the nation’s largest drugstore chains. On May 28, 2011, the company operated 4,704 stores compared to 4,767 stores in the like period a year ago. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com. Note that all sales data in this release is preliminary, unaudited and subject to revision. Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties that are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.